Extubation Advisor for Extubation

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
The Ottawa Hospital, General Campus, Ottawa, CanadaExtubationExtubation Advisor - Device
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial is assessing the feasibility of a new tool, the Extubation Advisor, to help with the decision of when to extubate a patient in the ICU.

Treatment Effectiveness

Effectiveness Progress

1 of 3

Similar Trials

1
ENLIGHT 2100 ventilatory electrical impedance tomograph
1
CPI-300
1
Paroxetine and Oxycodone

Study Objectives

5 Primary · 1 Secondary · Reporting Duration: Upon study completion, 4 months after study initiation

Month 4
Evaluate feasibility of capturing greater than 75% of wave form data
Evaluate feasibility of completing greater than 90% of clinical CRFs
Evaluate feasibility of enrolling and consenting greater than 50% of eligible patients
Evaluate feasibility of entering greater than 90% of participant clinical data into the Extubation Advisor tool
Evaluate feasibility of generating and delivering greater than 80% of Extubation Advisor reports to the attending physician
Evaluate opinions of Physicians and Respiratory Therapists regarding Extubation Advisor

Trial Safety

Safety Progress

1 of 3

Similar Trials

1
ENLIGHT 2100 ventilatory electrical impedance tomograph
1
CPI-300
1
Paroxetine and Oxycodone

Trial Design

1 Treatment Group

Intervention Arm
1 of 1

Experimental Treatment

72 Total Participants · 1 Treatment Group

Primary Treatment: Extubation Advisor · No Placebo Group · Phase 1

Intervention Arm
Device
Experimental Group · 1 Intervention: Extubation Advisor · Intervention Types: Device

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: upon study completion, 4 months after study initiation

Who is running the clinical trial?

Ottawa Hospital Research InstituteLead Sponsor
535 Previous Clinical Trials
2,512,084 Total Patients Enrolled
2 Trials studying Extubation
720 Patients Enrolled for Extubation
Andrew JE Seely, MD, PhD, FRCSCPrincipal InvestigatorThe Ottawa Hospital
1 Previous Clinical Trials
140 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 10 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
References

Frequently Asked Questions

What is the aggregate number of participants included in this research project?

"Affirmative. An inspection of the clinicaltrials.gov website reveals that this trial, which was initially published on October 4th 2021, is currently recruiting patients. The desired number of participants at one site totals 72 individuals." - Anonymous Online Contributor

Unverified Answer

What possible hazards exist when using Extubation Advisor?

"Our organisation has assigned the AI-driven medical tool Extubation Advisor a score of 1 on a scale from low to high risk due to it being in its initial phase and having limited research conducted on both safety and efficacy." - Anonymous Online Contributor

Unverified Answer

Are researchers actively seeking participants for this experiment?

"According to the details available on clinicaltrials.gov, this research trial is currently open for recruitment and was initially posted in October 2021 while its most recent update occurred in September of 2022." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top